Latest filing published 24 Aug 2026 for Dexcom Inc, €571k.
First 200 filings with a declared amount
Kevin R. Sayer (chief executive) discloses dealings in Dexcom Inc to SEC (Form 4). Between 20 January 2016 and 20 August 2026, the trades on record add up to 337 filings.
On the market, this insider has only sold: 281 sales, €163.4M in total. Outside the open market, there are 19 share grants and 12 option exercises. In 2026 alone, the filings show no purchases and 5 sales.
Most recently, on 24 August 2026, the filings show an open-market sale worth €571k in Dexcom Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. For comparison, the SEC allows two business days to file a Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 336 declarations